Simply Wall St.
CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed?
📈
AI Sentiment
Highly Positive
8/10
CytomX Therapeutics Inc. News
Latest updates and market news for CTMX
1 news
Feb 3 - Feb 9, 2026
Page 1
Share this news page